Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 18, 2023 (Week 46)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 15,666 32,999 1,312,501 1,476,257
New England 677 1,650 37,429 46,898
Connecticut - 430 1,155 11,035
Maine 52 74 2,640 2,817
Massachusetts 511 687 25,653 25,340
New Hampshire 43 82 2,473 2,516
Rhode Island 71 694 4,369 4,050
Vermont - 37 1,139 1,140
Middle Atlantic 2,409 4,176 174,032 171,556
New Jersey - 789 29,933 29,717
New York (excluding New York City) 977 1,032 37,399 35,638
New York City 514 1,497 59,076 57,324
Pennsylvania 918 1,231 47,624 48,877
East North Central 1,822 4,576 174,511 203,699
Illinois 82 1,811 46,700 63,389
Indiana 482 879 28,304 30,148
Michigan 285 912 29,597 38,284
Ohio 705 1,211 48,431 48,816
Wisconsin 268 562 21,479 23,062
West North Central 977 2,137 82,344 90,946
Iowa 183 333 12,082 13,185
Kansas 119 335 9,806 12,588
Minnesota 117 497 18,944 19,812
Missouri 519 746 28,392 28,727
Nebraska - 246 6,910 8,646
North Dakota 2 91 1,879 3,312
South Dakota 37 123 4,331 4,676
South Atlantic 3,729 7,719 286,114 329,237
Delaware - 226 4,895 4,602
District of Columbia 76 199 5,822 7,323
Florida 1,655 2,784 100,029 94,506
Georgia 668 1,550 52,373 65,205
Maryland U NC U 27,378
North Carolina 4 1,445 52,784 57,714
South Carolina 614 774 29,334 31,967
Virginia 677 976 37,014 36,514
West Virginia 35 115 3,863 4,028
East South Central 1,046 2,452 81,692 99,068
Alabama 598 972 30,312 27,751
Kentucky 346 546 14,990 16,200
Mississippi 102 487 16,140 20,901
Tennessee - 1,094 20,250 34,216
West South Central 641 4,837 177,648 207,527
Arkansas 215 435 15,315 16,116
Louisiana 262 873 31,928 32,659
Oklahoma 67 473 13,864 18,304
Texas 97 3,191 116,541 140,448
Mountain 1,748 2,557 97,388 105,241
Arizona 514 872 35,750 36,693
Colorado 704 777 22,587 23,380
Idaho 30 144 5,039 5,324
Montana 59 92 2,956 3,721
Nevada 230 343 10,514 14,505
New Mexico 19 253 9,292 10,085
Utah 192 255 9,860 9,923
Wyoming - 50 1,390 1,610
Pacific 2,617 5,049 201,343 222,085
Alaska 63 121 3,646 4,771
California 1,792 4,112 166,744 172,581
Hawaii - 132 - 4,916
Oregon 307 382 13,508 13,986
Washington 455 565 17,445 25,831
U.S. Territories - 102 1,138 4,191
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 102 1,138 4,191
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 5 46 127
Total 15,666 33,085 1,313,685 1,480,575
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.